UCB establishes research alliance with Harvard University
The alliance creates a drug discovery bridge between UCB and Harvard scientists to continue their research that holds potential for the development of new therapeutic modalities in clinical
miRecule has signed a research collaboration with EM subsidiary Rio Biofarma Brasil (RBBL) to co-develop peptide-mediated delivery technologies aimed at improving targeted ribonucleic acid (RNA) therapeutics delivery to tissues beyond the liver and muscles in a range of disease areas.